Oncology Molecular Diagnostics Market PDF: Industry Overview, Growth Rate

1. Global Oncology Molecular Diagnostics Market Research and Forecast Report 2021- 2026 Author: Elena Anderson, Marketing Manager | Copyright © IMARC Service Pvt Ltd. All Rights Reserved IMARC Group © 2019 IMARC All Rights Reserved

2. Report DescriptionAbout IMARC Group The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

3. Report Description and Highlights Report Description Global Oncology Molecular DiagnosticsMarket Research Report: According to the latest report by IMARC Group, titled "Oncology Molecular Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026," the global oncology molecular diagnostics market reached a strong growth in 2020. Oncology molecular diagnostics is a part of laboratory medicine that involves analyzing biological markers for the detection of cancer cells in an individual. In this process, blood, saliva, and tumor tissue sample tests are performed on the patient for measuring specific genetic sequences in the DNA, RNA and cell proteins. They are utilized for performing rapid analysis of the condition and providing detailed critical information regarding it. The quantitative measurements offered by the diagnostics are essential in understanding the stage and available effective therapeutic options for cancer. This aids in determining the right course of personalized treatment for the patient by making informed medical decisions for a better outcome. Request Free Sample Report: https://www.imarcgroup.com/oncology-molecular-diagnostics- market/requestsample

4. Report Description and Highlights Report Description Global Oncology Molecular Diagnostics Market Trends : The market is primarily driven by the growing prevalence of different forms of cancer across the globe. This can be attributed to the sedentary lifestyles led by the majority of the population, along with the high tobacco and alcohol uptake by the masses. Consequently, there is a significant increase in the demand for efficient diagnostic solutions, thereby providing a thrust to the market growth. Apart from this, the rising awareness regarding early cancer detection among individuals is acting as another major growth-inducing factor. Moreover, there has also been a considerable increase in the geriatric population on the global level. This, along with the growing investments by numerous private and public organizations to develop the oncology infrastructure across healthcare facilities, is creating a positive outlook for the market. Numerous players have also introduced technologically advanced diagnostics products in the market. Since these products offer enhanced accuracy and speed in terms of diagnosis while being affordable, they are gaining widespread prominence across the healthcare sector. Some of the other factors catalyzing the market growth include the increasing penetration of healthcare insurance in numerous developing countries and the rising trend of medical tourism on the global level. Looking forward, the market value is projected to reach a strong growth during the forecast period (2021- 2026).

5. Report Description and Highlights Report Description Market Summary: Breakup by Cancer Type: •Breast Cancer •Prostate Cancer •Colorectal Cancer •Cervical Cancer •Liver Cancer •Lung Cancer •Blood Cancer •Others Breakup by Product: •Instruments •Reagents •Others Breakup by Technology: •Polymerase Chain Reaction (PCR) •In Situ Hybridization •Chips and Microarrays •Isothermal Nucleic Acid Amplification Technology (INAAT)

6. Report Description Report Description and Highlights •Mass Spectrometry •DNA and NGS Sequencing •Transcription Mediated Amplification (TMA) •Others Breakup by End-User: •Hospitals and Clinics •Reference Laboratories •Others Breakup by Region: •North America • United States • Canada •Asia Pacific • China • Japan • India • South Korea • Australia

7. Report Description Report Description and Highlights • • Indonesia Others •Europe • • • • • • • Germany France United Kingdom Italy Spain Russia Others •Latin America • • • • • • • Brazil Mexico Argentina Columbia Chile Peru Others

8. Report Description Report Description and Highlights •Middle East and Africa Turkey •Saudi Arabia •Iran •United Arab Emirates •Others Note: We are updating our reports, If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report. Competitive Landscape with Key Players: • Agilent Technologies Inc. • Abbott Laboratories • Bayer AG • BD (Becton, Dickinson and Company) • Cepheid Inc. (Danaher Corporation) • F. Hoffmann-La Roche AG • Hologic Inc. • Qiagen N.V. • Siemens Healthcare • Sysmex Corporation.

9. Report Description Report Description and Highlights View Full Report with TOC & List of Figure: https://www.imarcgroup.com/oncology-molecular- diagnostics-market

10. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

11. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

12. Report Description and Highlights Report Description © 2019 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

13. Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com